Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gad Consulting Services is a private U.S. life sciences consulting firm focused on toxicology, risk assessment, and regulatory support for pharmaceutical and medical device companies. The company provides services spanning biocompatibility testing, impurity qualification, neurotoxicology, inhalation toxicology, immunotoxicology, animal models, nonclinical formulation, combination products, and GMP/GLP audit support. Its work appears concentrated on preclinical and early clinical development rather than on developing proprietary therapeutics. The firm also supports IND preparation and filings, and markets itself as having helped numerous clients advance programs through IND submission and Phase I readiness. Overall, Gad Consulting Services operates more like a specialized scientific and regulatory advisory firm than a product-focused biotech company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gad Consulting Services.